The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents.
Curtis JR, Xie F, Chen L, Baddley JW, Beukelman T, Saag KG, Spettell C, McMahan RM, Fernandes J, Winthrop K, et al. Ann Rheum Dis. 2011 Aug; 70(8):1401-6. Epub 2011 May 17.